Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hagenbeek

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Leukemia|November 1, 1992
Leukemic cell kill in autologous bone marrow transplantation: in vivo or in vitro?A Hagenbeek
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 13, 2013
Rituximab maintenance versus radio-immunotherapy consolidation in first remission follicular non-Hodgkin lymphomaA Hagenbeek
Leukemia|January 1, 1992
Minimal residual disease in leukemia: state of the art 1991A Hagenbeek
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Report of a European consensus workshop to develop recommendations for the optimal use of (90)Y-ibritumomab tiuxetan (Zevalin) in lymphomaA Hagenbeek, V Lewington
Leukemia Research|January 1, 1983
BCG treatment of residual disease in acute leukemia: studies in a rat model for human acute myelocytic leukemia (BNML)A Hagenbeek, A C Martens
Bailliere'S Clinical Haematology|July 1, 1991
Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML)A Hagenbeek, A C Martens
Radiation Research|March 1, 1981
Extracorporeal irradiation of the blood in a rat model for human acute myelocytic leukemia. Comparative evaluation of three treatment regimens with emphasis on cell compartment analysisA Hagenbeek, A C Martens
International Journal of Radiation Oncology, Biology, Physics|August 1, 1981
The effect of fractionated versus unfractionated total body irradiation on the growth of the BN acute myelocytic leukemiaA Hagenbeek, A C Martens
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemiaA C Martens, A Hagenbeek
Investigational New Drugs|January 1, 1984
Toxicity of ASTA Z 7557 (INN mafosfamide) to normal- and leukemic stem cells: implications for autologous bone marrow transplantationA Hagenbeek, A C Martens
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Leukemia|November 1, 1992
Leukemic cell kill in autologous bone marrow transplantation: in vivo or in vitro?A Hagenbeek
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 13, 2013
Rituximab maintenance versus radio-immunotherapy consolidation in first remission follicular non-Hodgkin lymphomaA Hagenbeek
Leukemia|January 1, 1992
Minimal residual disease in leukemia: state of the art 1991A Hagenbeek
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Report of a European consensus workshop to develop recommendations for the optimal use of (90)Y-ibritumomab tiuxetan (Zevalin) in lymphomaA Hagenbeek, V Lewington
Leukemia Research|January 1, 1983
BCG treatment of residual disease in acute leukemia: studies in a rat model for human acute myelocytic leukemia (BNML)A Hagenbeek, A C Martens
Bailliere'S Clinical Haematology|July 1, 1991
Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML)A Hagenbeek, A C Martens
Radiation Research|March 1, 1981
Extracorporeal irradiation of the blood in a rat model for human acute myelocytic leukemia. Comparative evaluation of three treatment regimens with emphasis on cell compartment analysisA Hagenbeek, A C Martens
International Journal of Radiation Oncology, Biology, Physics|August 1, 1981
The effect of fractionated versus unfractionated total body irradiation on the growth of the BN acute myelocytic leukemiaA Hagenbeek, A C Martens
European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemiaA C Martens, A Hagenbeek
Investigational New Drugs|January 1, 1984
Toxicity of ASTA Z 7557 (INN mafosfamide) to normal- and leukemic stem cells: implications for autologous bone marrow transplantationA Hagenbeek, A C Martens
Pageof 21